About EdgeBio
EdgeBio is a Healthcare company based in Gaithersburg (United States) founded in 1989, and was acquired by StoneCalibre in July 2014. DNA sequencing and purification products are manufactured and distributed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Genomics. Its competitors include Rejuvenate Bio, Genewiz and 20n; 2 of its 3 listed competitors have raised funding.
Company details
Manufacturer and distributor for DNA sequencing and purification. The company provides DNA sequencing and bioinformatics products and services for academic and government institutions, biopharmaceutical and biotechnology companies, and research institutions worldwide. Its services include clinical and research sequencing, consultation on experimental design, platforms, sample QC and library prep, data analysis, and bioinformatics support, biomarker sequencing, multiple target enrichment options, and automation and robotics. The companys products include sequencing clean-up, PCR purification, sample preparation, competent cells, and accessories.
- Headquarters Gaithersburg, United States
- Stage Acquired
- SectorsHealthcare
- Website edgebio.com/en
- Social LinkedIn X
- Acquired by StoneCalibre (Jul 2014)
- Latest Funding Round$109.38K (USD), Grant
Jul 2010
- InvestorsHHS
& 1 more
- Acquired byStoneCalibre
(Jul 2014)
Funding Insights of EdgeBio
- Total Rounds 1
- Last Round Grant — $109,380
- First Round $109,380
(Jul 2010)
- Investors Count 1
All 1 funding rounds of EdgeBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2010 | $109,380 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in EdgeBio
EdgeBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and StoneCalibre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
StoneCalibre is recognized as an international private investment firm. | 2012 | stonecalibre.com | Los Angeles, United States |
Investor details for EdgeBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of EdgeBio
3 dated milestones of EdgeBio across 25 years, from founding to its latest funding, stage changes and deals.
- Founded EdgeBio is founded.
- Funding First funding round of $109K.
- Exit Acquired by StoneCalibre.
Competitors of EdgeBio
EdgeBio has 3 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio, Genewiz and 20n.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. | ||
| 20n.com | 2013 | San Francisco, United States | $2.22M | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of EdgeBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EdgeBio
Websites that share an audience with EdgeBio (edgebio.com).
Websites whose visitors overlap most with EdgeBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| beckmancoulter.com | 100% | 113.9K | #341,469 | View details | |
| neb.com | 95% | 749.5K | #69,042 | View details | |
| qiagen.com | 93% | 458.2K | #105,023 | View details | |
| jcvi.org | 90% | 51.2K | #697,057 | View details | |
| coriell.org | 90% | 46.5K | #677,284 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 24 similar websites and full traffic analytics for EdgeBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 24 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as EdgeBio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EdgeBio
EdgeBio was founded in 1989 and raised its 1st funding round 21 years after it was founded.
EdgeBio is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Manufacturer and distributor for DNA sequencing and purification. The company provides DNA sequencing and bioinformatics products and services for academic and government institutions, biopharmaceutical and biotechnology companies, and research institutions worldwide. Its services include clinical and research sequencing, consultation on experimental design, platforms, sample QC and library prep, data analysis, and bioinformatics support, biomarker sequencing, multiple target enrichment options, and automation and robotics. The companys products include sequencing clean-up, PCR purification, sample preparation, competent cells, and accessories.
EdgeBio's top competitors include Genewiz, Rejuvenate Bio and 20n.
EdgeBio has 2 investors. Key investors include HHS, and StoneCalibre.
Yes. EdgeBio was acquired by StoneCalibre in July 2014.